3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
51
Neoplasms
36
Lung Neoplasms
25
Colorectal Neoplasms
24
Prostatic Neoplasms
15
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Hematologic Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Anxiety Disorders
9
Obesity
8
Lymphoma
8
Depression
8
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Melanoma
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Pain
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Smoking Cessation
4
Papillomavirus Infections
4
Interventions
Bupivacaine
11
Ketamine
9
Ropivacaine
8
Morphine
8
Acetaminophen
8
Fentanyl
7
Dexmedetomidine
7
Lidocaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Saline Solution
5
Anesthesia, Local
5
Acupuncture Therapy
5
parecoxib
4
Tramadol
4
Sodium Chloride
4
Pregabalin
4
Ethanol
4
Analgesia, Epidural
4
Transcutaneous Electric Nerve Stimulation
3
Radiofrequency Ablation
3
Propofol
3
Oxycodone
3
Ketorolac
3
Control Groups
3
Anesthetics, Local
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Therapeutics
2
Surveys and Questionnaires
2
Magnesium Sulfate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Agnosia
×
Methods
×
Clear all
NCT07332377
2026-03-18
PsyMINT
Virginia Commonwealth University
Phase NA
Recruiting
25 enrolled